Clinical Report: Investigation of Immune and Autophagy-Associated Genes in PMO
Overview
This study identifies key immune and autophagy-related genes in postmenopausal osteoporosis (PMO) and develops a diagnostic model with high predictive accuracy.
Background
Postmenopausal osteoporosis is a significant health concern characterized by decreased bone density and increased fracture risk in postmenopausal women. The interplay between immune dysregulation and autophagy is crucial in the pathogenesis of PMO.
Data Highlights
Hub Genes
Diagnostic Model AUC
Bone Density Changes
CDK2, DDIT3, MAPK8
0.91
Reduced in OVX mice
Key Findings
Three hub genes (CDK2, DDIT3, MAPK8) were identified as critical in PMO.
The diagnostic model demonstrated high predictive accuracy with an AUC of 0.91.
GSEA indicated that CDK2 and DDIT3 are linked to ligand-receptor interaction pathways.
Hub genes showed significant correlation with immune cell infiltration alterations.
In vivo studies in OVX mice revealed decreased bone density and altered serum biomarkers.
Clinical Implications
The identification of immune-autophagy-related genes provides potential biomarkers for diagnosing PMO.
Conclusion
The study successfully developed a diagnostic model based on immune-autophagy interactions, enhancing the understanding of PMO.
